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ABSTRACT Plasminogen activator inhibitor 1 harbors four tryptophan residues at positions 86, 139, 175, and 262. To
investigate the contribution of each tryptophan residue to the total ﬂuorescence and to reveal the mutual interactions of the
tryptophan residues and interactions with the other amino acids, 15 mutants in which tryptophan residues have been replaced by
phenylalanines were constructed, puriﬁed, and characterized. Conformational distribution analysis revealed that the tryptophan
mutants have a similar conformational distribution pattern as wild-type plasminogen activator inhibitor 1. Mutants in which
tryptophan residue 175 was replaced by a phenylalanine displayed an increased functional half-life of the active conformation,
whereas the functional half-life of mutants in which tryptophan residue 262 was replaced by a phenylalanine was substantially
decreased. Comparative analysis of the ﬂuorescence lifetimes, the extinction coefﬁcients, and the quantum yields of the
individual tryptophan residues demonstrates that tryptophan residue 262 gives the highest contribution to the total ﬂuorescence.
The other tryptophan residues have a very low quantum yield. In the wild-type protein, the ﬂuorescence of all tryptophan residues
is partially quenched as compared to the mutants that contain single tryptophan residues, due to conformational effects. The
ﬂuorescence of tryptophan residue 262 is very likely also partially quenched by energy transfer to tryptophan residue 175.
INTRODUCTION
Plasminogen activator inhibitor 1 (PAI-1) is the most
important physiological inhibitor of tissue-type and uroki-
nase-type plasminogen activator. It is a 50-kDa protein with
379 amino acids belonging to the serpin superfamily
(Andreasen et al., 1986; Ginsburg et al., 1986; Ny et al.,
1986; Pannekoek et al., 1986). All serpins consist of three b-
sheets, nine a-helices (A through I), and a reactive site loop
containing residues P16–P109, which are highly variable
(Gils and Declerck, 1998). The reactive site loop, situated
30–40 amino acids from the carboxy-terminal end, harbors
a ‘‘bait’’ residue (P1 residue) that mimics the normal
substrate of the target proteinase (Laskowski and Kato,
1980). In PAI-1, the Arg346-Met347 bond has been identiﬁed
as the P1-P19 bond (Lindahl et al., 1990). The protein plays
an important role in the equilibrium between blood clot
formation and blood clot lysis (Nilsson et al., 1985; Juhan
Vague et al., 1995; Wiman, 1999). PAI-1 is synthesized as an
active molecule that spontaneously converts into a latent
form that cannot inhibit the target protease. The latent form
can partially be reactivated by denaturants such as guanidi-
nium chloride, sodium dodecyl sulfate, or urea (Hekman and
Loskutoff, 1985). The spontaneous conversion to the latent
form is unique for PAI-1. Even though for two other serpins
a latent form has been described (Carrell et al., 1994; Lomas
et al., 1995; Chang and Lomas, 1998), these could only be
generated under denaturing conditions. This change in
conformation has recently been described by computational
methods (Kru¨ger et al., 2001). PAI-1 can also occur in a stable
noninhibitory cleavable substrate conformation (Declerck
et al., 1992; Urano et al., 1992; Munch et al., 1993).
The x-ray structures of PAI-1 in the latent (Mottonen et al.,
1992), the cleaved substrate (PAI-1 mutant in which alanine
at position 335 is mutated into a proline) (Aertgeerts et al.,
1995a), and recently the active conformation are known (Nar
et al., 2000). The x-ray structure of the enzyme/inhibitor
complex is not yet known. In the latent conformation, the
P15–P4 residues insert into b-sheet A and the P4–P109
residues form an extended loop on the surface of the molecule
(Mottonen et al., 1992). Therefore, the latent conformation
cannot interact with the target proteinases at the P1-P19 site.
PAI-1 harbors four tryptophans at positions 86, 139, 175,
and 262 (see Fig. 1). Tryptophan residue 86 is located at the
turn connecting helix D with strand s2A. Among the serpins,
this tryptophan residue is unique for PAI-1. Tryptophan
residue 139 is located on the internal side of helix F and is
conserved in antithrombin III and in PAI-1. Tryptophan
residue 175 is conserved in most of the inhibitory serpins and
is located in the turn connecting strand 3A with strand 4C.
Tryptophan residue 262 is conserved in a1-antichymotrypsin
and antithrombin III and is situated in helix H.
To study the contribution of each of the tryptophans to the
total ﬂuorescence of the protein in more detail, we have
constructed, puriﬁed, and characterized 15 tryptophan
mutants in which tryptophans have been replaced by
a phenylalanine. This study reveals the importance of the
tryptophan side chains on the kinetic stability of the active
conformation. It shows that the ﬂuorescence of tryptophan
residue 262 gives the highest contribution to the total protein
ﬂuorescence, and that the ﬂuorescence of all tryptophan
residues is partially quenched in the wild-type protein, as
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compared to the mutants containing only a single tryptophan
residue, whereas the ﬂuorescence of tryptophan residue 262
is very likely also quenched by energy transfer to tryptophan
residue 175.
EXPERIMENTAL PROCEDURES
Materials
Restriction enzymes were obtained from Amersham Biosciences (Uppsala,
Sweden) or from Boehringer Mannheim (Brussels, Belgium). T4 DNA
ligase, the Klenow fragment of Escherichia coli DNA polymerase I, and
alkaline phosphatase were purchased from Boehringer Mannheim (Brussels,
Belgium). The oligonucleotide-directed mutagenesis system (the pMa/c
plasmids; (Stanssens et al., 1989)) was kindly provided by Corvas (Ghent,
Belgium). The oligonucleotides for mutagenesis were purchased from
Amersham Biosciences. M13KO7 helper phage was obtained from Promega
(Leiden, The Netherlands). The expression vector pIGE20 was kindly
provided by Innogenetics (Ghent, Belgium), together with the bacterial
strains E. coli DH1l for cloning and E. coliMC1061 for expression as well
as the pAcI plasmid encoding the thermolabile repressor. The chromogenic
substrate S-2403was obtained fromChromogenix (Mo¨lndal, Sweden). T-PA
(predominantly single chain) was a kind gift from Boehringer Ingelheim
(Brussels, Belgium).
Construction, expression and puriﬁcation
of PAI-1 and PAI-1 mutants
In vitro site-directed mutagenesis of PAI-1 was performed as described
earlier (Audenaert et al., 1994) using the pMa/c system and the following
synthetic oligonucleotides to obtain the desired mutation:
PrimW86F: 59 CGTCTGTAGTACTGATCTCGTCCTTGTTAAATGGC 39
PrimW139F: 59 GTGTGTCTTCACAAAGTCATTGATGATG 39
PrimW175F: 59 GGGGAAGGGAGTTTTAAACTGGCCG 39
PrimW262F: 59 GGTCATGTTGCCTTTAAAGTGGCTGATGAGC 39.
Except for primer PrimW139F, speciﬁc restriction sites were introduced
(AGTACT ScaI-site or TTTAAA DraI-site) to allow conﬁrmation of the
induced mutation. SacI-XbaI fragments from the pMa-PAI-1-mutants were
recovered and substituted for the SacI-XbaI in pIGE20-wild-type (wt)-PAI-
1. Transformations of E. coli were performed using the calcium chloride
method (Sambrook et al., 1989). Nucleotide sequencing using an Automatic
Laser Fluorescence Detection Unit (ALF sequencer, Amersham Bioscien-
ces) was used to conﬁrm the desired mutation. Expression and puriﬁcation of
wt-PAI-1 and PAI-1 mutants was performed in E. coli as described earlier
(Gils et al., 1996). Extinction coefﬁcients at 280 nm were determined as
described by Mach et al. (1992). The extinction coefﬁcients at 295 nm were
determined by taking the proportion of the absorbance at 280 nm and 295
nm into account, and corrected as described by Mach et al. (1992).
Conformational distribution of PAI-1 mutants
PAI-1 samples were diluted with phosphate buffered saline (140 mM NaCl,
2.7 mM KCl, 8 mM Na2HPO4, 1.5 mM KH2PO4) to a concentration of 0.3
mg/ml and incubated for 30 min at 378C with a ﬁvefold molar excess of
t-PA. The reaction was terminated by adding sodium dodecyl sulfate (ﬁnal
concentration 1%) and heating for 30 s at 1008C. Reaction products were
analyzed by sodium dodecyl sulfate polyacrylamide gel electrophoresis
using 10–15% gradient gels under nonreducing conditions with the Phast
system (Amersham Biosciences). Proteins were visualized by staining with
Coomassie brilliant blue. Reaction products were quantiﬁed with the
Imagemaster using densitometric scanning (Amersham Biosciences).
Determination of the kinetic stability of
puriﬁed wt-PAI-1 and PAI-1 variants at 378C
Puriﬁed PAI-1 samples were diluted to a ﬁnal concentration of 50–120 mg/
ml to obtain a buffered solution with 45 mM phosphate pH 7.4 and 70 mM
NaCl. Samples were incubated at 378C and aliquots were removed at various
times and assayed for inhibitory activity toward t-PA.
Fluorescence lifetime measurements at 108C
Isolation of the reactive form of wt-PAI-1 and PAI-1 variants from the latent
form was performed as described previously (Declerck et al., 1992). In brief,
FIGURE 1 (A) Active conformation of PAI-1 with tryptophan residues
86, 139, 175, and 262, respectively highlighted in yellow, green, red and
blue. (B) The different tryptophan residues in PAI-1 with their mutual
distances, k2 values, and possible ﬂuorescence quenchers.
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reactive wt-PAI-1 or PAI-1 variants were applied to immobilized t-PA-
S478A, the nonbinding fraction (¼latent form) was collected, and bound
PAI-1 (¼reactive form) was eluted with 1.5 MNaCl in 0.1 M sodium acetate
pH 5.5.
All ﬂuorescence measurements were done at 108C to hinder the
conversion of the reactive form into latent. Fluorescence lifetimes were
measured using automatic multifrequency phase ﬂuorometry between 1.6
MHz and 1 GHz as described previously (Sillen et al., 2000). N-acetyl-
tryptophanamide in aqueous solution was used as a reference with a lifetime
of 3.789 ns at 108C. The measured phase shifts, f, at a modulation
frequency, v, of the exciting light are related to the ﬂuorescence decay in the
time domain I(t),
IðtÞ ¼ +
i
ai exp
t
ti
 
(1)
where ai is the amplitude of the ﬂuorescence signal of the component with
lifetime ti, by means of the following equations (Weber, 1981):
tanfðvÞ ¼ SðvÞ
GðvÞ (2)
where S(v) and G(v) are the sine and cosine Fourier transforms of I(t)
SðvÞ ¼ +
i
fi
vti
ð11v2t2i Þ
(3)
GðvÞ ¼ +
i
fi
1
ð11v2t2i Þ
(4)
and fi is the steady-state contribution of the component with phase shift fi
fi ¼ aiti+
i
aiti
: (5)
Quantum yield measurements at 108C
Fluorescence measurements were performed on a SPEX spectroﬂuorometer
(Fluorolog-1691, Spex Industries, Edison, NJ) with excitation and emission
slits at 7.2 and 3.6 nm, respectively. For selective observation of the
tryptophan residues, an excitation wavelength of 295 nm was used. All
measurements were done at a temperature of 108C. All ﬂuorescence spectra
were corrected for the buffer and the wavelength dependence of the emission
monochromator and the photomultiplier. The quantum yields were
determined relative to N-acetyltryptophanamide in aqueous solution
according to the method of Parker and Rees (1960) using a quantum yield
for N-acetyltryptophanamide in water of 0.177 at 108C:
Qprot ¼
Ð
IprotÐ
INATA
ANATA
Aprot
QNATA (6)
where
R
I is the integrated intensity over the wavelength region 300–450 nm,
Q is the quantum yield, and A is the absorbance at 295 nm.
Calculation of k2
The geometric orientation factor (k) has been calculated from:
k
2 ¼ ðcos uT  3 cos uD cos uAÞ2 (7)
where uT is the angle between the emission dipole of the donor and the
absorption dipole of the acceptor, and uD and uA are the angles between
these dipoles and the vector joining the midpoints of the CE2/CD2 bond of
the donor and the acceptor, respectively. Indole has two excited states
termed 1La and
1Lb (Valeur and Weber, 1977). The direction of transition
moment of the 1La state was deﬁned according to Ichiye and Karplus (1983).
That of 1Lb was assumed to be at 888 relative to
1La. The values found are
shown in Fig. 1.
RESULTS
Conformational distribution of wt-PAI-1
and PAI-1 mutants at 378C
Despite the fact that all mutations were successfully
constructed in the pIGE20-wt-PAI-1 vector, sequenced and
transformed in E. coliMC1061 cells, the expression level of
PAI-1-W86-139F and PAI-1-W175-262F was very low. As
a consequence, further experiments could not be done with
these mutants.
Incubation of wt-PAI-1 and the tryptophan mutants with
a ﬁvefold molar excess of t-PA all revealed the formation of
t-PA/PAI-1 complexes originating from the active con-
formation—small amounts of cleaved derivative originating
from the substrate form and residual nonreactive material
being the latent form. The relative fractions of each mutant
are displayed in Table 1.
Functional (kinetic) stability of PAI-1
mutants at 378C
Wt-PAI-1 and PAI-1 mutants were incubated at 378C and the
remaining PAI-1 activity was determined at various time
intervals. Table 2 shows the functional half-life of wt-PAI-1
and PAI-1-mutants. This half-life characterizes the loss of
active fraction as a function of time at 378C.
In comparison with the half-life of wt-PAI-1 (108 6 18
min), the mutants in which tryptophan residue 262 is replaced
by a phenylalanine have a short half-life and the mutants in
which tryptophan residue 175 is replaced by a phenylalanine
TABLE 1 Conformational distribution (expressed in %)
of wt-PAI-1 and PAI-1 variants upon incubation with a
ﬁvefold molar excess of t-PA
PAI-1 variants Active (%) Substrate (%) Latent (%)
wt-PAI-1 53 11 36
PAI-1-W86F 59 17 24
PAI-1-W139F 57 10 33
PAI-1-W175F 68 15 17
PAI-1-W262F 52 9 39
PAI-1-W86-139F N.D.* N.D. N.D.
PAI-1-W86-175F 71 13 16
PAI-1-W86-262F 76 7 17
PAI-1-W139-175F 86 11 3
PAI-1-W139-262F 73 15 12
PAI-1-W175-262F N.D. N.D. N.D.
PAI-1-W86-139-175F 77 19 4
PAI-1-W86-139-262F 69 14 17
PAI-1-W86-175-262F 80 17 3
PAI-1-W139-175-262F 69 28 3
PAI-1-W86-139-175-262F 53 44 3
*N.D., not determined.
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have a longer half-life. Mutating either tryptophan residue 86
or tryptophan residue 139 into phenylalanine has no effect on
the functional stability of PAI-1. When both tryptophan
residues 262 and 175 are replaced by a phenylalanine, the
functional half-life is shortened.
Fluorescence spectrophotometry of the
active form at 108C
After separation of the reactive forms from the latent forms,
the quantum yields and ﬂuorescence lifetimes were mea-
sured of the reactive forms. The ﬂuorescence decay pa-
rameters were determined at emission wavelengths ranging
from 320 to 380 nm in 10 nm intervals. Depending on
the mutant, best ﬁt (lowest x2—no systematic deviation in
the autocorrelation function or the weighted residuals) was
obtained with a double- or triple-exponential ﬁt.
Fig. 2 displays the phase shifts, the ﬁtted curves, and the
residuals values as a function of the frequency, together with
the autocorrelation of the residuals for (A) PAI-1-W139-175-
262F and (B) PAI-1-W86-139-175F. Both measurements
were ﬁtted with a two-exponential decay function. Fittings
with a three-exponential decay function resulted in three
lifetimes, two of which were the same.
Fig. 3 on the other hand displays the phase shifts, ﬁtted
curve, and residuals together with the autocorrelation of the
residuals for PAI-1-W86-139-262F. This mutant was ﬁtted
with a three-exponential function (A) and a two-exponential
function (B). The graphs clearly show that ﬁtting with a three-
exponential decay function gives the best result. To increase
the accuracy of the recovery of the lifetimes and the fractional
intensities, a global analysis of all the phase measurements at
the different wavelengths was performed. This means that
all the phase data were ﬁtted with a single set of two or three
lifetimes and at each wavelength a separate set of three
amplitude fractions. There were no signiﬁcant differences
observed between the amplitude fractions at different wave-
lengths. The different quantum yields and ﬂuorescence life-
times are shown in Tables 3 and 4, respectively.
The mutants in which tryptophan residue 262 is replaced
TABLE 2 Functional half-life at 378C (expressed in minutes)
of wt-PAI-1 and PAI-1 variants
PAI-1 variants Functional half-life (min)
wt-PAI-1 108 6 18*
PAI-1-W86F 121 6 19
PAI-1-W139F 111 6 14
PAI-1-W175F 282 6 17
PAI-1-W262F 17 6 2
PAI-1-W86-139F N.D.y
PAI-1-W86-175F 200 6 32
PAI-1-W86-262F 15 6 2
PAI-1-W139-175F 291 6 29
PAI-1-W139-262F 15 6 1
PAI-1-W175-262F N.D.
PAI-1-W86-139-175F 320 6 33
PAI-1-W86-139-262F 22 6 5
PAI-1-W86-175-262F 17 6 2
PAI-1-W139-175-262F 18 6 3
PAI-1-W86-139-175-262F 20 6 3
*Mean 6 SD, n ¼ 3.
yN.D., not determined.
FIGURE 2 Representation of a phase measurement with the ﬁt against their two-exponential function, the respective residuals, and autocorrelation functions
of (A) PAI-1-W139-175-262F and (B) PAI-1-W86-139-175F.
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by a phenylalanine have a lower quantum yield compared to
wt-PAI-1 except for PAI-1-W139-262F. In contrast, the
mutants in which tryptophan residues 139 and 175 are
replaced by a phenylalanine have a higher quantum yield
except for those mutants in which tryptophan residue 262 is
also replaced by a phenylalanine.
There are three ﬂuorescence lifetimes present in wt-PAI-1
around 0.6 ns, 2.2 ns, and 5.3 ns. The shortest lifetime only
appears when tryptophan residue 175 is present. The other
two lifetimes are more or less the same for all mutants.
Besides the mutants with a low expression level, the
ﬂuorescence lifetimes of PAI-1-W86-175-262F and PAI-1-
W86-139-175-262F could not be measured because of very
low ﬂuorescence intensities.
DISCUSSION
Conformational properties of the
tryptophan residues
The primary intention of making the tryptophan mutants
was to study the contribution of each individual tryptophan
residue to the total ﬂuorescence of wt-PAI-1 and to map the
dissipation of the excited-state energy, and in this way learn
more about protein ﬂuorescence in general. This includes the
energy transfer between the tryptophan residues as well as
the interactions with the surrounding residues. In this study,
the replacement of tryptophan by phenylalanine residues was
chosen since both residues are aromatic. We didn’t choose
for replacement by tyrosine since a high number of tyrosine
residues could interfere with our ﬂuorescence measurements
despite the fact that an excitation wavelength of 295 nm was
used. The chosen mutations were expected to have little
inﬂuence on the stability of PAI-1. However, comparing the
functional half-life of wt-PAI-1 (108 6 18 min) with the
functional half-lives of the tryptophan mutants, the impor-
tance of tryptophan residues at positions 262 and 175 in the
kinetics of the conversion of active to latent PAI-1 appears
clearly.
During the conversion from the active to the latent form,
the C-terminal portion of the reactive center loop (RCL) has
to move through a gate formed between two loops,
designated ‘‘loop 1’’ (residues 185–200) and ‘‘loop 2’’
(residues 242–246) (Aertgeerts et al., 1995b), resulting in i),
the disruption of s1C (strand 1 of b-sheet C) (Mottonen et al.,
1992) and ii), the concomitant insertion of the N-terminal
portion (P14-P4) of the RCL into b-sheet A, thus forming an
additional strand s4A (strand 4 of b-sheet A). The transition
pad of this conversion was recently described at an atomic
level using simulation techniques (Kru¨ger et al., 2001).
The present study reveals that replacement of the
tryptophan residue at position 175 strongly increases the
kinetic stability of PAI-1. This tryptophan residue is po-
sitioned in the turn between strand 3A and strand 4C.
Visual inspection of the structure reveals that tryptophan
residue 175 could inﬂuence i), the movement of the RCL
because it gets in close contact during the transition, ii), the
insertion of the N-terminal portion of the RCL into b-sheet
FIGURE 3 Representation of a phase measurement of PAI-1-W86-139-
262F ﬁtted with (A) a three-exponential function and (B) a two-exponential
function, the respective residuals, and autocorrelation functions.
TABLE 3 Experimental and calculated quantum yields at 108C
of the reactive conformations of wt-PAI-1 and PAI-1 variants
PAI-1 variants Quantum yield Calculated Q*
wt-PAI-1 0.085 6 0.008y 0.159 and 0.083z
PAI-1-W86F 0.098 6 0.007 0.185
PAI-1-W139F 0.126 6 0.015 0.192
PAI-1-W175F 0.155 6 0.009 0.182
PAI-1-W262F 0.060 6 0.007 0.058
PAI-1-W86-139F N.D.§ –
PAI-1-W86-175F 0.223 6 0.021 0.225
PAI-1-W86-262F 0.043 6 0.007 0.052
PAI-1-W139-175F 0.250 6 0.021 0.233
PAI-1-W139-262F 0.092 6 0.006 0.071
PAI-1-W175-262F N.D. –
PAI-1-W86-139-175F 0.331 6 0.033 0.127{
PAI-1-W86-139-262F 0.075 6 0.009 0.179{
PAI-1-W86-175-262F 0.029 6 0.011 0.078{
PAI-1-W139-175-262F 0.067 6 0.007 0.0383{
PAI-1-W86-139-175-262F 0.009 6 0.002 –
*Calculated additively from data of the single tryptophans.
yMean 6 SD, n ¼ 3.
zCalculated additively from data of single tryptophan residues W86, W139,
and W175 1 Q from W262 as present in wt (¼0.127).
§N.D., not determined.
{Calculated subtractively from data of wt and 1W-mutants.
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A, and iii), the mobility of ‘‘loop 1’’ thus again affecting the
movement of the RCL during the transition.
Replacement of tryptophan residue 262 results in a de-
crease in functional (kinetic) stability indicating that
a tryptophan at this position hinders the conformational
transition. Tryptophan residue 262 is positioned at the end of
helix H near turn thHs2C (the turn between helix H and
strand 2C). We assume that a mutation at position 262 will
inﬂuence the mobility of ‘‘loop 2’’, thereby affecting the
movement of the C-terminal portion of the RCL through the
gate formed by ‘‘loop 1’’ and ‘‘loop 2’’. The turn at which
tryptophan residue 262 is positioned is also in close
proximity with ‘‘loop 1’’ so this can also inﬂuence the
movement of the RCL.
The mutants in which both tryptophan residues 262 and
175 are replaced by a phenylalanine show a half-life com-
parable to the functional half-life of the mutants in which
only tryptophan residue 262 is replaced by a phenylalanine.
So both mutations together do not neutralize one another.
In contrast, the replacement of tryptophan residue 262 by a
phenylalanine is not at all inﬂuenced by the other mutations,
indicating the importance of a tryptophan residue at posi-
tion 262.
Although we can clearly see the effect of these mutations
on the kinetics of the conformational change, it cannot be
automatically assumed that these mutations will alter the
reactive conformation in a dramatic way. The difference in
equilibrium fractions are rather small and even the kinetics
suggest rather small effects. We base this conclusion on the
fact that the maximal effect of the mutations is an increase of
the rate constant for deactivation with a factor of 10. This
corresponds to a change in DG* at room temperature of
;1.38 kCal/mol or 5.5 kJ/mol. This is not a big change.
Removing one hydrogen bridge would be sufﬁcient to
destabilize the starting state with this value (Pace et al.,
1991). The same result could be obtained by stabilizing the
transition state with one hydrogen bridge. Therefore we
conclude that changes in the overall conformation of the
active state cannot be very dramatic.
Fluorescence properties of the individual
tryptophan residues
Fluorescence spectra
To calculate the quantum yields, the steady-state spectra had
to be measured. Therefore, we were able to assign the four
tryptophans of PAI-1 to one of the ﬁve classes of tryptophan
residues according to Burstein and coworkers (Reshetnyak
et al., 2001). Both tryptophan residues 139 (lmax ¼ 324 nm)
and 175 (lmax ¼ 324 nm) belong to Class S and tryptophan
residues 86 (lmax ¼ 328 nm) and 262 (lmax ¼ 330 nm) can
be classiﬁed as Class I.
Quantum yields
The experimental quantum yields of wt-PAI-1 and the PAI-1
variants are shown in Table 3. It should be realized that these
quantum yields are the average quantum yields of the
individual tryptophan residues present in the mutants. It is
remarkable that removing tryptophan residues 86, 139, and
175 individually results in an increased average quantum
yield compared to the wild-type reference, whereas re-
moving tryptophan residue 262 results in a decreased value.
This already indicates that the individual quantum yields of
tryptophan residues 86, 139, and 175 must be lower than the
average value in the wild-type, and the quantum yield of
tryptophan residue 262 must be higher.
This is conﬁrmed by looking at the quantum yields of the
individual tryptophan residues.
TABLE 4 Different ﬂuorescence lifetimes (ti) together with their amplitude fractions (ai), x
2 value, mean amplitude lifetime hti,
and Q/hti values of the reactive conformations of wt-PAI-1 and PAI-1 variants measured at 108C
PAI-1 variants a1 t1 a2 t2 a3 t3 x
2 hti Q/hti
wt-PAI-1 0.307* (0.044) 0.624 (0.095) 0.394 (0.026) 2.158 (0.247) 0.299 (0.047) 5.349 (0.274) 2.780 2.641 0.031
PAI-1-W86F 0.288 (0.032) 0.495 (0.087) 0.265 (0.022) 2.180 (0.452) 0.446 (0.074) 5.532 (0.198) 1.804 3.188 0.029
PAI-1-W139F 0.348 (0.027) 0.833 (0.087) 0.262 (0.030) 2.522 (0.389) 0.390 (0.054) 5.416 (0.195) 2.568 3.063 0.039
PAI-1-W175F – – 0.246 (0.085) 1.921 (0.411) 0.754 (0.231) 5.355 (0.333) 3.566 4.510 0.032
PAI-1-W262F 0.449 (0.028) 0.543 (0.048) 0.498 (0.021) 1.938 (0.092) 0.053 (0.004) 5.344 (0.284) 2.658 1.492 0.0375
PAI-1-W86-139F N.D.y N.D. N.D. N.D. N.D. N.D. N.D. N.D. N.D.
PAI-1-W86-175F – – 0.251 (0.068) 1.912 (0.324) 0.749 (0.124) 5.289 (0.276) 3.654 4.441 0.046
PAI-1-W86-262F 0.561 (0.019) 0.487 (0.026) 0.389 (0.018) 2.050 (0.087) 0.050 (0.003) 5.550 (0.208) 2.842 1.348 0.029
PAI-1-W139-175F – – 0.278 (0.016) 2.121 (0.094) 0.722 (0.042) 5.425 (0.111) 1.806 4.506 0.051
PAI-1-W139-262F 0.247 (0.022) 0.455 (0.083) 0.602 (0.018) 1.919 (0.081) 0.151 (0.009) 5.285 (0.184) 1.908 2.065 0.040
PAI-W175-262F N.D. N.D. N.D. N.D. N.D. N.D. N.D. N.D. N.D.
PAI-1-W86-139-175F – – 0.122 (0.023) 2.512 (0.335) 0.878 (0.166) 5.596 (0.140) 1.808 5.220 0.056
PAI-1-W86-139-262F 0.398 (0.032) 0.481 (0.057) 0.510 (0.023) 1.886 (0.126) 0.091 (0.011) 5.180 (0.241) 2.356 1.625 0.038
PAI-1-W86-175-262F N.D. N.D. N.D. N.D. N.D. N.D. N.D. N.D. N.D.
PAI-1-W139-175-262F – – 0.668 (0.058) 2.157 (0.120) 0.332 (0.029) 5.523 (0.289) 1.766 3.275 0.017
*Mean (SD), n ¼ 3.
yN.D., not determined.
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In a multi-tryptophan protein, the ﬂuorescence quantum
yield of an individual tryptophan can be obtained in two
ways (De Beuckeleer et al., 1999). It can be obtained
experimentally from the single-tryptophan containing pro-
tein where all the other tryptophan residues have been
replaced by a phenylalanine (Qi,exp). It can also be calculated
by subtraction (Qi,calc) from the quantum yield of the wild-
type and of the mutant protein where only the concerned
tryptophan has been removed (1W-mutants). The two
values do not have to be the same. In the ﬁrst case, the
tryptophan is not inﬂuenced by other tryptophan residues; in
the second case, the quantum yield of a tryptophan can be
inﬂuenced by energy transfer to or from the other tryptophan
residues. In both cases the results can also be inﬂuenced by
conformational changes induced by the mutations. These are
more likely to occur in the mutants where more than one
tryptophan has been replaced.
To calculate the quantum yield of the concerned
tryptophan, the calculated ﬂuorescence intensity of the mu-
tant protein is subtracted from the calculated intensity of the
wild-type and divided by its own extinction coefﬁcient at
295 nm. The intensities mentioned are always calculated
from the quantum yields and the appropriate extinction co-
efﬁcients (ei) (Table 5):
Qi;calc ¼
Qwt3 +
j
ej  QðiÞ3 +
j6¼i
ej
ei
: (8)
Table 3 shows the calculated quantum yields obtained in
this way for the single-tryptophan mutants (Q). The results
show that the quantum yields of the tryptophan residues 86
and 262 are higher when they are single tryptophan resid-
ues than when they are present in the wild-type, indicating
that they are losing energy, e.g., by energy transfer or
conformational effects. The calculated quantum yields of
tryptophan residues 139 and 175 are even negative in the
wild-type, indicating that they are decreasing the quantum
yield of the other tryptophan residues.
In the additive method the quantum yield of a protein
containing more than one tryptophan residue is calculated by
averaging the quantum yields of the individual isolated
tryptophan residues, taking their extinction coefﬁcient into
account.
Qn ¼
+
n
1
eiQi
+
n
1
ei
: (9)
The results (Table 3) show that for the mutants containing
two tryptophan residues, the calculated average quantum
yields agree within 10%–20% with the experimental ones.
When looking at the calculated quantum yields of the three
tryptophan-containing proteins, only the quantum yield of
PAI-1-W262F is correctly calculated. Whenever tryptophan
residue 262 is present, the experimental quantum yield is a lot
smaller than the calculated one. This suggests that the
presence of tryptophan residue 262 induces severe quenching
of the protein ﬂuorescence compared to the sum of the single
tryptophans. It is tempting to attribute this quenching effect to
energy transfer from the high quantum yield tryptophan
residue 262 to the other residues, e.g., to tryptophan residue
175 at 1.9 nm distance. The calculated efﬁciency of energy
transfer is indeed 63%. We calculated an R0 value of 2.1 nm,
which is much bigger than the R0 of 1.1 nm for the tryptophan
residues in Barnase (Willaert et al., 1992). The value of k2
calculated was linked to the most probable 1La-
1La transition.
The values for the less probable 1La-
1Lb transitions are smaller
in all cases. The distances between the other tryptophan
residues are much larger and their k2 values are lower, which
results in energy transfer efﬁciencies among the other
tryptophan residues always to be lower than 1%. The con-
clusion is therefore that introducing tryptophan residue 262
brings in a high-intensity tryptophan that is partially quenched
by energy transfer to tryptophan residue 175. Taking into
account the efﬁciency of this energy transfer and the quantum
yield of the acceptor, we calculate a new quantum yield for
tryptophan residue 262 in wt equal to 0.169, which is still
higher than the one directly observed. Therefore we must
assume that additional quenching is due to a conformational
change that leads to quenching of the protein ﬂuorescence,
and we cannot exclude that this conformational effect could
be responsible for a large part of the quenching effect.
Fluorescence lifetimes
One would expect that a single tryptophan residue should
have only one excited state lifetime. Actually, tryptophan
TABLE 5 Extinction coefﬁcients at 280 nm of different PAI-1-variants, ratio of the absorbance at 295 nm and 280 nm (corrected
according to Mach et al. (1992)), and extinction coefﬁcients of the tryptophan residues at 295 nm, corrected for the
contribution of the tyrosine residues at 295 nm (PAI-1-W86-139-175-262F)
Tryptophan residue e280 nm (M
1cm1) PAI-1 variant A295 nm/A280 nm e295 nm (M
1cm1) Trp residue
86 (PAI-1-W139-175-262F) 18860 0.172 2628
139 (PAI-1-W86-175-262F) 18860 0.161 2421
175 (PAI-1-W86-139-262F) 18860 0.167 2534
262 (PAI-1-W86-139-175F) 18860 0.271 4495
PAI-1-W86-139-175-262F 13050 0.047 –
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ﬂuorescence in proteins is known to exhibit multiexponential
decay of which the origins are not completely understood
(Callis, 1999). The existence of multiple ﬂuorescence
lifetimes for a single tryptophan residue could be due to
excited state reactions (Lakowicz, 2000) or the existence of
multiple ground states (e.g., rotamers) (Szabo and Rayner,
1980; Bajzer and Prendergast, 1993; Brown and Royer,
1997; Ababou and Bombarda, 2001). Hudson (1999)
proposed a model that involves reversible ionization of the
excited tryptophan residue due to collisional transfer of an
electron to a neighboring residue. Other groups have also
suggested the involvement of an electron transfer process as
the principal quenching mechanism in proteins and peptides
(Antonini et al., 1997; Chen and Barkley et al., 1998;
Ababou et al., 2001). In the absence of quenching side
chains, the carbonyl group of the peptide itself is thought to
be the responsible quencher (Ricci and Nesta, 1976; Chen
et al., 1998; Sillen et al., 2000; Adams et al., 2002). Since no
difference is seen in amplitude fractions at different wave-
lengths, it is safe to assume that in PAI-1, the cause for
multiple ﬂuorescence lifetimes could lie in the existence of
multiple microstates. Multiple protein micro conformations
(Dahms et al., 1995) cause different interactions of the
tryptophan side chain with amino acid groups of the
surrounding protein matrix (Bajzer and Prendergast, 1993;
Chen and Barkley, 1998). The longer lifetimes are thought to
originate from conformations with little interaction with the
environment or long distances between the indole ring and
the peptide carbonyl, whereas the shorter lifetimes are the
result of quenching from the solvent or the protein matrix
(Chen et al., 1996).
From a ﬁrst observation of the ﬂuorescence lifetimes, we
can conclude that the smallest ﬂuorescence lifetime (;0.5
ns) originates from tryptophan residue 175, because this
ﬂuorescence lifetime doesn’t appear in the absence of
this tryptophan residue. Together with the analysis of the
quantum yields, this is a clear indication that this tryptophan
residue is dynamically quenched by its environment. After
closer investigation of its environment, two possible
quenchers appear: methionine residue 235 (distance ;0.4
nm) and tyrosine residue 228 (the aromatic rings of the two
residues are situated parallel to each other within a distance
of ;0.45 nm).
Tryptophan residue 139 must be quenched, as indicated by
the small quantum yield of PAI-1-W86-175-262F. Although
the ﬂuorescence lifetimes of PAI-1-W86-175-262F could
not be determined, an average lifetime of hti ﬃ 1 ns is
calculated starting from data of the mutants PAI-1-W86-
175F and PAI-1-W86-139-175F. Since there is no clear
indication for energy transfer between tryptophan residues
262 and 139, we can calculate the Q/hti value (which is the
radiative rate constant kr) for PAI-1-W86-175-262F (trypto-
phan residue 139) starting from the Q/hti values of PAI-1-
W86-175F (tryptophan residues 139 and 262 present) and
PAI-1-W86-139-175F (tryptophan residue 262), taking the
extinction coefﬁcients into account (Sillen and Engelborghs,
1998).
Q
t
 
W1391W262
¼
eW2623
Q
t
 
W262
1 eW1393
Q
t
 
W139
eW2621 eW139
:
(10)
Since the Q value is known for PAI-1-W86-175-262F, the
hti value is easily calculated. This is a clear indication that
tryptophan residue 139 is dynamically quenched. This
dynamic quenching is possible by the presence of histidine
residue 143, which is in close proximity of tryptophan
residue 139 (;0.36 nm).
In the same manner, the kr values for the other double
mutants can be calculated, starting from the measured val-
ues of the triple tryptophan mutants (only one tryptophan
present). The calculated and measured values should not
differ, despite the fact that energy transfer or dynamic
quenching could occur. Only static quenching or a change of
kr will inﬂuence these parameters. One must keep in mind
that these values can still differ somewhat because the
propagation of the errors of the measurements. In case of
PAI-1-W86-262F and PAI-1-W139-175F, the measured kr
values (0.029 and 0.051, respectively) are close the cal-
culated values (0.033 and 0.044, respectively). There is, how-
ever, a larger difference between the measured (0.040) and
calculated (0.029) kr values of PAI-1-W139-262F. This can
be due to larger errors in the measurements, or a change in
conformational distribution.
The quantum yield of W86 is also very low. We assume
this is due to static quenching, as clearly indicated by the Q/
hti (Sillen et al., 1999) value of PAI-1-W139-175-262F. In
this case, the value is very low (0.017) in comparison with
the Q/hti value of wt-PAI-1 (0.031). The Q/hti value will be
independent of the fact that the ﬂuorophore is dynamically
quenched or not. When the quantum yield decreases due to
a dynamic quencher, the htiwill decrease to the same extent.
But in case of static quenching, the quantum yield will
decrease, but hti will stay unaffected, so the Q/hti value will
be small. At a ﬁrst sight, there is no clear indication why
tryptophan residue 86 is quenched. The only quenching
residue in the neighborhood is histidine residue 364 at
a distance of ;0.35 nm. Although histidine is basically
a dynamic quencher (Vos and Engelborghs, 1994), a very
high frequency of interactions between the histidine residue
TABLE 6 Functional half-life at 378C and quantum yields
at 108C of the reactive conformations of PAI-1 variants,
constructed to reveal possible quenchers
PAI-1 variants Functional half-life (min) Quantum yield
PAI-1-H143N 123 6 37* 0.145 6 0.014*
PAI-1-H364N 12 6 4 0.149 6 0.029
PAI-1-Y228F 13 6 5 0.076 6 0.021
*Mean 6 SD, n ¼ 3.
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and the tryptophan residue, thereby causing very fast dy-
namic quenching that escapes lifetime measurements, could
be interpreted as static quenching (Webber, 1997).
To check the assumptions made in the last three para-
graphs on the possible quenchers of tryptophan residues 86,
139, and 175, three mutants were constructed and puriﬁed,
i.e., PAI-1-H143N, PAI-1-H364N, and PAI-1-Y228F. The
functional half-lives as well as the quantum yields are dis-
played in Table 6.
Because of the low expression levels, there was in-
sufﬁcient material to determine the ﬂuorescence lifetimes
of these mutants. To see directly the effect of the possible
quenchers on their neighboring tryptophan residues without
the inﬂuence of the other tryptophan residues, the mutants
PAI-1-H143N-W86-175-262F and PAI-1-H364N-W139-
175-262F were also constructed, but the expression levels
were too low to perform any measurements.
The mutant PAI-1-H143N has a functional half-life of 123
6 37 min, which is very similar to that of wt-PAI-1. This
mutant was constructed to investigate if histidine residue 143
is a quencher of tryptophan residue 139. The quantum yield
of this mutant is signiﬁcantly larger than that of wt-PAI-1
and therefore we can conclude that this histidine residue is
a possible quencher of tryptophan residue 139.
The mutant PAI-1-H364N was constructed to investigate
the inﬂuence of histidine residue 364 on the ﬂuorescence of
tryptophan residue 86. This mutant has a signiﬁcantly larger
quantum yield than wt-PAI-1, which suggests that histidine
residue 364 is indeed a static quencher of tryptophan residue
86. Unfortunately the mutant has a functional half-life of 12
6 4 min, which is signiﬁcantly smaller than wt-PAI-1.
Therefore there exists the possibility that introducing the
asparagine residue caused a conformational change.
The mutant PAI-1-Y228F was constructed to investigate
the inﬂuence of tyrosine residue 228 on the ﬂuorescence of
residue 175. Again, this mutant has a signiﬁcant smaller half-
life than wt-PAI-1, but more important, the quantum yield is
not signiﬁcantly different from wt-PAI-1. Therefore, we can
assume that this tyrosine residue cannot be considered as
a quencher of tryptophan residue 175.
CONCLUSION
Two issues are clearly illustrated in this paper. First, the
importance of tryptophan residues as large rigid amino acids
emerges in thekinetics of the conformational changeofPAI-1.
Although the tryptophan residues in PAI-1 are not directly
involved in the movement of the reactive center loop,
tryptophan residues 262 and 175 inﬂuence the transition
from the active to the latent conformation. While this
paper was being reviewed, a paper appeared that also
demonstrates the role of the tryptophan residues in the
kinetics of the conformational changes, based on the
results obtained with 7-azatryptophan mutants (Blouse
et al., 2002).
We also show that the overall ﬂuorescence properties of
PAI-1 are governed mainly by the ﬂuorescence of residue,
i.e., tryptophan residue 262. The other residues have a very
low quantum yield and the reasons are identiﬁed. Additivity
of the quantum yields holds as long as tryptophan residue 262
is absent.When tryptophan residue 262 is introduced, a strong
quenching appears, probably partially due to energy transfer
to tryptophan residue 175 and partially to a conformational
effect that leads to quenching of the protein ﬂuorescence.
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